CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
4,673,367
Share change
-2,084,377
Total reported value
$482,000
Price per share
$0.10
Number of holders
15
Value change
-$257,488
Number of buys
4
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q3 2019

As of 30 Sep 2019, CANCER GENETICS INC - COM (CGIX) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,673,367 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, UBS Group AG, DIKER MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA SECURITIES, LLC, First PREMIER Bank, ROYAL BANK OF CANADA, and PERKINS CAPITAL MANAGEMENT INC. This page lists 15 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.